Insulin glargine and lixisenatide Subcutaneous and Linagliptin and metformin
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Linagliptin and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Linagliptin and Metformin Extended-Release Tablets
- Insulin glargine and lixisenatide Subcutaneous-Linagliptin and Metformin Tablets
- Insulin glargine and lixisenatide Subcutaneous-Lincocin
- Insulin glargine and lixisenatide Subcutaneous-Lincomycin
- Insulin glargine and lixisenatide Subcutaneous-Lincomycin Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Lincomycin Injection
- Linagliptin and metformin-Insulin glargine, recombinant Subcutaneous
- Linagliptin and metformin-Insulin glulisine
- Linagliptin and metformin-Insulin Glulisine (Cartridges and Pens)
- Linagliptin and metformin-Insulin Glulisine (Vials)
- Linagliptin and metformin-Insulin glulisine Subcutaneous
- Linagliptin and metformin-Insulin human inhaled Inhalation